In light of recent research, the potential role of chromium picolinate in modulating inflammatory responses, particularly through reducing IL-6 levels, suggests that it could play a dual role in managing both metabolic and inflammatory aspects of PCOS. The gene discussed is IL6; the disease is polycystic ovary syndrome.